Your browser doesn't support javascript.
loading
Multicenter, 2-dose single-group controlled trial of tacrolimus for the severe infertility patients.
Hisano, Michi; Nakagawa, Koji; Ono, Masanori; Yoshino, Osamu; Saito, Takakazu; Hirota, Yasushi; Inoue, Eisuke; Kikuchi, Kayoko; Nakamura, Hidefumi; Yamaguchi, Koushi.
Afiliação
  • Hisano M; Center of Maternal-Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development, Tokyo, Japan.
  • Nakagawa K; Center for Reproductive Medicine and Implantation Research, Sugiyama Clinic Shinjuku, Tokyo, Japan.
  • Ono M; Department of Obstetrics and Gynecology, Tokyo Medical University, Tokyo, Japan.
  • Yoshino O; Department of Obstetrics and Gynecology, Yamanashi University, Yamanashi, Japan.
  • Saito T; Center of Maternal-Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development, Tokyo, Japan.
  • Hirota Y; Department of Obstetrics and Gynecology, The University of Tokyo, Tokyo, Japan.
  • Inoue E; Showa University Research Administration Center, Showa University, Tokyo, Japan.
  • Kikuchi K; Translational Research Headquarters, Fujita Health University, Aichi, Japan.
  • Nakamura H; Department of Research and Development Supervision, National Center for Child Health and Development, Tokyo, Japan.
  • Yamaguchi K; Center of Maternal-Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development, Tokyo, Japan.
Medicine (Baltimore) ; 102(32): e34317, 2023 Aug 11.
Article em En | MEDLINE | ID: mdl-37565878

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Aborto Espontâneo / Infertilidade Feminina Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Aborto Espontâneo / Infertilidade Feminina Idioma: En Ano de publicação: 2023 Tipo de documento: Article